Literature DB >> 19910946

Medication errors in chronic kidney disease: one piece in the patient safety puzzle.

Jeffrey C Fink1, Glenn M Chertow.   

Abstract

Patients with chronic kidney disease (CKD) are at increased risk of harm as a consequence of errors in medical care. Hug and colleagues highlight the significance of adverse drug events in hospitalized patients with CKD. Their findings demonstrate the role adverse drug events play in the safety of patients with CKD and underscore the importance of novel strategies intended to reduce such medical errors.

Entities:  

Mesh:

Year:  2009        PMID: 19910946     DOI: 10.1038/ki.2009.315

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Management of drug toxicity in patients with renal insufficiency.

Authors:  Claudio Ponticelli; Giorgio Graziani
Journal:  Nat Rev Nephrol       Date:  2010-06       Impact factor: 28.314

2.  Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study.

Authors:  Gaëlle Breton; Marc Froissart; Nicolas Janus; Vincent Launay-Vacher; Claudine Berr; Christophe Tzourio; Catherine Helmer; Benedicte Stengel
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

3.  Patient-reported and actionable safety events in CKD.

Authors:  Jennifer S Ginsberg; Min Zhan; Clarissa J Diamantidis; Corinne Woods; Jingjing Chen; Jeffrey C Fink
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

4.  Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD.

Authors:  Clarissa J Diamantidis; Jennifer S Ginsberg; Marni Yoffe; Lisa Lucas; Divya Prakash; Saurabh Aggarwal; Wanda Fink; Stefan Becker; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-28       Impact factor: 8.237

5.  Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital.

Authors:  Ping Yang; Na Chen; Rong-Rong Wang; Lu Li; Sai-Ping Jiang
Journal:  Ther Clin Risk Manag       Date:  2016-10-12       Impact factor: 2.423

6.  Evaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in Lebanon.

Authors:  Rayane Saad; Souheil Hallit; Bahia Chahine
Journal:  Pharm Pract (Granada)       Date:  2019-02-27

7.  Setting an agenda for comparative effectiveness systematic reviews in CKD care.

Authors:  Deidra C Crews; Raquel C Greer; Jeffrey J Fadrowski; Michael J Choi; David Doggett; Jodi B Segal; Kemi A Fawole; Pammie R Crawford; L Ebony Boulware
Journal:  BMC Nephrol       Date:  2012-08-01       Impact factor: 2.388

8.  Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.

Authors:  Henok Getachew; Yewondwossen Tadesse; Workineh Shibeshi
Journal:  BMC Nephrol       Date:  2015-10-07       Impact factor: 2.388

9.  Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing.

Authors:  Majed Alshamrani; Abdullah Almalki; Mohamed Qureshi; Oyindamola Yusuf; Sherine Ismail
Journal:  Pharmacy (Basel)       Date:  2018-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.